Sponsor Pipeline

Design Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07024693 DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy Fuchs Endothelial Corneal Dystrophy Recruiting
Phase 1/2
NCT06874010 A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia Friedreich Ataxia Recruiting
Phase 1
NCT06772870 A Single Ascending Dose Study of DT-216P2 in Normal Healthy Participants Friedreich Ataxia Not Yet Recruiting
Get alerts when Design Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free